Magleby Cataxinos & Greenwood

Ex parte reexamination requester·4 ex parte reexams

Magleby Cataxinos & Greenwood has requested 4 USPTO ex parte reexaminations. It most often challenges patents owned by BAYER CROPSCIENCE N.V. and BAYER INTELLECTUAL PROPERTY GMBH. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.

Filings by year

2
14
2
15

Outcome track record

How this requester's challenges resolve: claims confirmed, amended, mixed, or fully canceled.

  • Certificate outcome split across every bucket
  • Share of challenges that canceled claims

Challenge metrics

Cancellation rate, average pendency, and the open/closed split across every reexam this requester has filed.

  • Outcome rate of closed challenges
  • Average pendency in months

Examiners & defense counsel

Which examiners decide this requester's challenges, and which firms defend the targeted patents.

  • Most frequent examiners
  • Top opposing counsel

Recent reexaminations (4)

Control #FiledPatentTitleOwnerStatus
90/013,563Aug 7, 2015RE44,962GENETICALLY ENGINEERED PLANT CELLS AND PLANTS EXHIBITING RESISTANCE TO GLUTAMINE SYNTHETASE INHIBITORS, DNA FRAGMENTS AND RECOMBINANTS FOR USE IN THE PRODUCTION OF SAID CELLS AND PLANTSBAYER CROPSCIENCE N.V.Closed
90/013,515Jun 1, 2015RE44,962GENETICALLY ENGINEERED PLANT CELLS AND PLANTS EXHIBITING RESISTANCE TO GLUTAMINE SYNTHETASE INHIBITORS, DNA FRAGMENTS AND RECOMBINANTS FOR USE IN THE PRODUCTION OF SAID CELLS AND PLANTSBAYER CROPSCIENCE N.V.Closed
90/013,394Nov 7, 2014RE44,962GENETICALLY ENGINEERED PLANT CELLS AND PLANTS EXHIBITING RESISTANCE TO GLUTAMINE SYNTHETASE INHIBITORS, DNA FRAGMENTS AND RECOMBINANTS FOR USE IN THE PRODUCTION OF SAID CELLS AND PLANTSBAYER CROPSCIENCE N.V.Closed
90/013,216May 19, 20147,105,470HERBICIDAL COMPOSITIONS FOR TOLERANT OR RESISTANT SOYBEAN CROPSBAYER INTELLECTUAL PROPERTY GMBHClosed

See the full reexam picture for Magleby Cataxinos & Greenwood

Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.